Novel agents in the treatment of lung cancer: advances in EGFR-targeted agents. Proceedings of the Third Cambridge Conference. September 23-24, 2005. Cambridge, Massachusetts, USA.
D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000201:enzymology; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology
D066246:ErbB Receptors